Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease
睡眠中断与早期阿尔茨海默病中 Tau 蛋白积累和网络失调有关
基本信息
- 批准号:9988329
- 负责人:
- 金额:$ 84.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:Abeta synthesisAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAmyloidAmyloid beta-ProteinAnimalsArchitectureAttentionBehaviorBiological MarkersBrainCaregiver BurdenChronicClinicalCognitionCognitiveDataDepositionDiseaseDisease ProgressionEquationEvolutionFactor AnalysisFamily health statusFrequenciesFunctional Magnetic Resonance ImagingGroupingHealthcare SystemsHomeHumanImaging TechniquesImpaired cognitionIndividualInferiorInterventionIntervention StudiesLinkMagnetic Resonance ImagingMeasurableMeasuresMediatingMediator of activation proteinMemoryMemory impairmentModelingNeuropsychological TestsNeuropsychologyParticipantPathologicPathologyPathway interactionsPatientsPatternPerformancePhasePittsburgh Compound-BPolysomnographyPopulationPositron-Emission TomographyProductionProteinsPublic HealthPublishingREM SleepRestRiskSleepSleep Apnea SyndromesSleep ArchitectureSleep disturbancesSpecific qualifier valueStructureSyndromeTimeVisitactigraphyanalysis pipelinebasecognitive performancecohortdesigndisease natural historyhuman dataimprovedin vivoindexingmemory consolidationmild cognitive impairmentmolecular pathologyneocorticalnetwork dysfunctionneural networknon rapid eye movementpoor sleepprodromal Alzheimer&aposs diseaserapid eye movementrecruittau Proteinstau aggregationtherapeutic targettherapy designβ-amyloid burden
项目摘要
Project Summary/Abstract:
Based on animal and limited human data, sleep disruption has been linked to decreased clearance and
increased production of b-amyloid and tau, proteins which in their aggregated forms represent the two
hallmark pathologies seen in Alzheimer’s disease. A number of different sleep parameters have also been
closely tied to memory consolidation and chronic sleep disruption increases the risk of memory impairment in
older individuals. However, despite data linking sleep disruption to Alzheimer’s disease pathology and
memory impairment, significant gaps remain in our understanding of how sleep disruption evolves over the
course of Mild Cognitive Impairment (MCI) and what aspects of sleep may be targets for intervention. In this
context, we propose to directly examine the evolution of sleep disruption in relation to the in vivo progression
of tau pathology, cognitive decline, and network dysfunction. Leveraging data that suggest that tau
accumulation may be quite rapid during prodromal Alzheimer’s disease, we will focus these studies on
individuals with MCI. We hypothesize that disrupted sleep architecture will be closely related to increased
neocortical tau pathology and cognitive impairment, both cross-sectionally and longitudinally. Further, we
hypothesize that sleep disruption leads to diminished connectivity in brain networks previously linked to
memory performance and cognitive decline, and that this network dysregulation may partially mediate the
effects of sleep disruption on cognition. Together, these studies will improve understanding on mechanistic
links between sleep, cognition, and Alzheimer’s disease. More broadly, the data from these studies will
critically inform the design of interventional studies modifying sleep in early Alzheimer’s disease by identifying
which specific aspects of disrupted sleep are most closely tied to b-amyloid and tau pathology (potential
therapeutic targets), assessing which aspects of sleep change over time in MCI, and the extent to which
longitudinal polysomnography and actigraphy can measure aspects of sleep disruption relevant to Alzheimer’s
disease.
项目摘要/摘要:
根据动物和有限的人类数据,睡眠中断与清除率降低和
b-淀粉样蛋白和 tau 蛋白的产生增加,这两种蛋白质以聚集形式代表
阿尔茨海默病的标志性病理学也有许多不同的睡眠参数。
与记忆巩固和慢性睡眠中断密切相关,会增加记忆障碍的风险
然而,尽管有数据表明睡眠障碍与阿尔茨海默病的病理学有关。
记忆障碍,我们对睡眠中断如何演变的理解仍然存在重大差距
轻度认知障碍 (MCI) 的病程以及睡眠的哪些方面可能是干预的目标。
在这种情况下,我们建议直接检查睡眠中断的演变与体内进展的关系
利用表明 tau 蛋白病理学、认知能力下降和网络功能障碍的数据。
在阿尔茨海默病前驱期,积累可能相当快,我们将重点关注这些研究
我们认为睡眠结构紊乱与 MCI 增加密切相关。
新皮质 tau 蛋白病理学和认知障碍,无论是横向还是纵向。
睡眠中断会导致先前与睡眠有关的大脑网络的连接性减弱
记忆力和认知能力下降,这种网络失调可能部分介导
睡眠中断对认知的影响 总之,这些研究将增进对机制的理解。
更广泛地说,这些研究的数据将揭示睡眠、认知和阿尔茨海默病之间的联系。
通过识别来改变早期阿尔茨海默病的睡眠,为干预研究的设计提供重要信息
睡眠中断的哪些具体方面与 b-淀粉样蛋白和 tau 蛋白病理学关系最密切(潜在
治疗目标),评估 MCI 中睡眠的哪些方面随时间变化,以及变化的程度
纵向多导睡眠图和体动记录仪可以测量与阿尔茨海默病相关的睡眠中断的各个方面
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASMEER P CHHATWAL其他文献
JASMEER P CHHATWAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASMEER P CHHATWAL', 18)}}的其他基金
Leveraging Heterogeneity in Autosomal Dominant AD to Elucidate Pathophysiology and Improve AD Biomarkers
利用常染色体显性 AD 的异质性阐明病理生理学并改善 AD 生物标志物
- 批准号:
10539956 - 财政年份:2022
- 资助金额:
$ 84.71万 - 项目类别:
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
血浆 tau 蛋白和神经退行性标记物作为 AD 进展率的预测因子
- 批准号:
10633231 - 财政年份:2021
- 资助金额:
$ 84.71万 - 项目类别:
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
血浆 tau 蛋白和神经退行性标记物作为 AD 进展率的预测因子
- 批准号:
10184985 - 财政年份:2021
- 资助金额:
$ 84.71万 - 项目类别:
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
血浆 tau 蛋白和神经退行性标记物作为 AD 进展率的预测因子
- 批准号:
10491047 - 财政年份:2021
- 资助金额:
$ 84.71万 - 项目类别:
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease
睡眠中断与早期阿尔茨海默病中 Tau 蛋白积累和网络失调有关
- 批准号:
10629334 - 财政年份:2019
- 资助金额:
$ 84.71万 - 项目类别:
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease
睡眠中断与早期阿尔茨海默病中 Tau 蛋白积累和网络失调有关
- 批准号:
10442358 - 财政年份:2019
- 资助金额:
$ 84.71万 - 项目类别:
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD
年龄和遗传对常染色体显性和散发性 AD 中 fcMRI 网络的影响
- 批准号:
9127072 - 财政年份:2015
- 资助金额:
$ 84.71万 - 项目类别:
Age and genetic influence on fcMRI networks in autosomal dominant and sporadic AD
年龄和遗传对常染色体显性和散发性 AD 中 fcMRI 网络的影响
- 批准号:
9265410 - 财政年份:2015
- 资助金额:
$ 84.71万 - 项目类别:
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)
血管因素、体力活动和炎症作为神经退行性和认知轨迹的调节剂(项目 2)
- 批准号:
10541811 - 财政年份:2010
- 资助金额:
$ 84.71万 - 项目类别:
Inhibitory interneurons: Fear conditioning/extinction
抑制性中间神经元:恐惧调节/消退
- 批准号:
6836231 - 财政年份:2004
- 资助金额:
$ 84.71万 - 项目类别:
相似国自然基金
基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于miRNA介导ceRNA网络调控作用的防治阿尔茨海默病及认知障碍相关疾病药物的发现研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
LMTK1调控核内体转运介导阿尔茨海默病神经元Reserve机制研究
- 批准号:81903703
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于自组装多肽纳米探针检测蛋白标志物用于阿尔茨海默病精准诊断的研究
- 批准号:31900984
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
- 批准号:
10722422 - 财政年份:2023
- 资助金额:
$ 84.71万 - 项目类别:
PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5
通过靶向 CCR5 预防 HIV 感染中的阿尔茨海默病样脑部病变
- 批准号:
10700624 - 财政年份:2023
- 资助金额:
$ 84.71万 - 项目类别:
Mechanistic dissection of allosteric modulation and nonproteolytic chaperone activity of human insulin-degrading enzyme
人胰岛素降解酶变构调节和非蛋白水解伴侣活性的机制剖析
- 批准号:
10667987 - 财政年份:2023
- 资助金额:
$ 84.71万 - 项目类别:
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
阿尔茨海默病和 SARS-CoV-2 感染的相关痴呆样后遗症:病毒-宿主相互作用组、神经病理生物学和药物再利用
- 批准号:
10661931 - 财政年份:2023
- 资助金额:
$ 84.71万 - 项目类别:
miR-29: A brain homeostasis molecule for Alzheimer’s disease prevention
miR-29:一种用于预防阿尔茨海默病的大脑稳态分子
- 批准号:
10667151 - 财政年份:2023
- 资助金额:
$ 84.71万 - 项目类别: